Skip to main content
Erschienen in: Rheumatology International 10/2014

01.10.2014 | Short Communication

Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis

verfasst von: Patompong Ungprasert, Anawin Sanguankeo

Erschienen in: Rheumatology International | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

We performed this meta-analysis to assess venous thromboembolism risk in patients with idiopathic inflammatory myositis (IIM). A comprehensive search was performed in MEDLINE, EMBASE and the Cochrane database. Three observational studies met our inclusion criteria and were included in the data analysis. The pooled risk ratio of venous thromboembolism in patients with IIM compared with non-IIM participants was 2.85 (95 % CI 2.12–3.84). Our result indicates a significant increased risk of venous thromboembolism among patients with IIM.
Literatur
1.
Zurück zum Zitat Naess IA, Christiansen SC, Romundstad P et al (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692–699PubMedCrossRef Naess IA, Christiansen SC, Romundstad P et al (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692–699PubMedCrossRef
2.
Zurück zum Zitat Heit JA, Silverstein MD, Mohr DN et al (1999) Predictor of survival after deep venous thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 159:445–453PubMedCrossRef Heit JA, Silverstein MD, Mohr DN et al (1999) Predictor of survival after deep venous thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 159:445–453PubMedCrossRef
4.
Zurück zum Zitat Silvarino R, Danza A, Merola V, Berez A, Mendez E, Espinosa G, Cervera R (2012) Venous thromboembolic disease in systemic autoimmune diseases: an association to keep in mind. Autoimmun Rev 12:289–294PubMedCrossRef Silvarino R, Danza A, Merola V, Berez A, Mendez E, Espinosa G, Cervera R (2012) Venous thromboembolic disease in systemic autoimmune diseases: an association to keep in mind. Autoimmun Rev 12:289–294PubMedCrossRef
5.
Zurück zum Zitat Ungprasert P, Srivali N, Spanuchart I et al (2014) Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 33:297–304PubMedCrossRef Ungprasert P, Srivali N, Spanuchart I et al (2014) Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 33:297–304PubMedCrossRef
6.
Zurück zum Zitat Miehsler W, Reinisch W, Valic E et al (2005) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542–548CrossRef Miehsler W, Reinisch W, Valic E et al (2005) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542–548CrossRef
7.
Zurück zum Zitat Selva-O’callaghan A, Fernandez-Luque A, Martinez-Gomez X et al (2011) Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol 29:846–849PubMed Selva-O’callaghan A, Fernandez-Luque A, Martinez-Gomez X et al (2011) Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol 29:846–849PubMed
8.
Zurück zum Zitat Gaitonde SD, Ballou SP (2008) Deep venous thrombosis in dermatomyositis. J Rheumatol 35(11):2288PubMedCrossRef Gaitonde SD, Ballou SP (2008) Deep venous thrombosis in dermatomyositis. J Rheumatol 35(11):2288PubMedCrossRef
9.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188CrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188CrossRef
11.
Zurück zum Zitat Ramagopalan SV, Wotton CJ, Handel AE et al (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 9:1PubMedCrossRefPubMedCentral Ramagopalan SV, Wotton CJ, Handel AE et al (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 9:1PubMedCrossRefPubMedCentral
12.
Zurück zum Zitat Zoller B, Li X, Sunquist J, Sunquist K (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 379:244–249PubMedCrossRef Zoller B, Li X, Sunquist J, Sunquist K (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 379:244–249PubMedCrossRef
13.
Zurück zum Zitat Johannesdottir SA, Schmidt M, Horvath-Puho E et al (2012) Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case–control study. J Thromb Haemost 10:815–821PubMedCrossRef Johannesdottir SA, Schmidt M, Horvath-Puho E et al (2012) Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case–control study. J Thromb Haemost 10:815–821PubMedCrossRef
14.
Zurück zum Zitat Biasillio G, Leo M, Della Bona R et al (2010) Inflammatory biomarker and coronary artery disease: from bench to bedside and back. Intern Emerg Med 5:225–233CrossRef Biasillio G, Leo M, Della Bona R et al (2010) Inflammatory biomarker and coronary artery disease: from bench to bedside and back. Intern Emerg Med 5:225–233CrossRef
15.
Zurück zum Zitat Jezovnik MK, Poredos P (2010) Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29:226–231PubMed Jezovnik MK, Poredos P (2010) Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29:226–231PubMed
16.
Zurück zum Zitat Fumery M, Xiaocang C, Dauchet L et al (2013) Thrombotic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis, 29 Oct 2013 [Epub ahead of print] Fumery M, Xiaocang C, Dauchet L et al (2013) Thrombotic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis, 29 Oct 2013 [Epub ahead of print]
17.
Zurück zum Zitat Ungprasert P, Leeaphorn N, Hosiriluck N et al (2013) Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population. ISRN Rheumatol 2013:509354PubMedCrossRefPubMedCentral Ungprasert P, Leeaphorn N, Hosiriluck N et al (2013) Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population. ISRN Rheumatol 2013:509354PubMedCrossRefPubMedCentral
Metadaten
Titel
Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis
verfasst von
Patompong Ungprasert
Anawin Sanguankeo
Publikationsdatum
01.10.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 10/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3023-1

Weitere Artikel der Ausgabe 10/2014

Rheumatology International 10/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.